HOME >> MEDICINE >> NEWS
Advances In Translational Cancer Research Is Focus Of 90th Annual Meeting Of American Association For Cancer Research

Philadelphia, March 30, 1999 -- Cancer researchers from around the world will meet in April at the 90th Annual Meeting of American Association for Cancer Research (AACR) to share cutting-edge research findings in the rapidly advancing areas of translational research and molecular genetics, including anti-angiogenesis agents, cancer vaccines, gene therapy, and molecular targeted therapy. The meeting will take place from April 10-14 at the Pennsylvania Convention Center in Philadelphia, and will feature close to 5,000 abstracts and 200 invited presentations. Two special late-breaking research sessions will offer reports of highly significant and timely findings that have occurred within the last few months. A new feature at the Annual Meeting is a special lecture, given this year by Nobel Laureate James D. Watson, Ph.D., entitled "From the Double Helix to DNA Tumor Viruses."

"As the pace of scientific discovery accelerates, it is essential to present the most up-to-date and novel information to the scientific community and the public in order to make progress against cancer," said Webster K. Cavenee Ph.D., President of AACR and Director, Ludwig Institute for Cancer Research in La Jolla, CA. "To that end, we have been closely monitoring scientific developments and will present research on the latest research findings in all of the subdisciplines of cancer research."

"For the last five months, the 90th Annual Meeting Program Committee has been working to examine the entire field of cancer research and identify the most rapidly developing research areas, as well as the most appropriate scientists to organize the sessions in which these new data will be presented," said Waun Ki Hong, M.D., American Cancer Society Clinical Research Professor, Professor and Chairman, Department of Thoracic/Head and Neck Oncology, UT M.D. Anderson Cancer Center, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Chairperson of the AACR Program C
'"/>

Contact: Jack Cooley
jcooley@cwg.com
212-886-2200
Cooney Waters Group, Inc.
4-Apr-1999


Page: 1 2 3 4

Related medicine news :

1. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
2. Advances in plasma physics at Annual APS Meeting
3. Advances in plasma physics at Annual APS Meeting
4. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Advances emerging in hepatitis management
7. Advances in prevention and treatment research hold promise for pipeline
8. Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis
9. Peanut Allergy: Major Advances in Treatment and Education
10. "Radical" Discovery Advances Medicine and Plastics
11. Advances in On the Spot tests have huge public health implications

Post Your Comments:
(Date:7/31/2015)... ... 2015 , ... Intellitec Solutions announced today they have expanded ... GP for a senior living facility in Maine. Having achieved recognition as a ... 16 states. This further expansion was again a factor of the firm’s success ...
(Date:7/30/2015)... ... , ... When responsible for the care of an aging loved one, summer ... mind: What happens if mom falls? Who will remind Dad to take his medications? ... But not taking time away from caregiving responsibilities can lead to bigger problems – ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... On July ... meeting in Manatee county to discuss plausible solutions for controlling the heroin outbreak. Ultimately ... event of an overdose is largely perpetuating the heroin crisis in North Florida. The ...
(Date:7/30/2015)... Austin, Texas (PRWEB) , ... July 30, 2015 ... ... Critical Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that ... Dyslipidemia have been published for use on the CDISC website . These ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating coach Simone Myers ... for women interested in improving their love lives using specific "lines" designed to ... to the public early this morning, has drawn praise from several dating and ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
(Date:7/30/2015)... LAGUNA HILLS, Calif. , July 30, 2015 ... developing nanoparticle drug delivery platforms, has received Orphan ... (FDA) for a second drug product that uses ... is a formulation of dactinomycin for the treatment ... bone cancer. The FDA granted NanoSmart,s Orphan Drug ...
(Date:7/30/2015)... , July 30, 2015  Arena Pharmaceuticals, Inc. (NASDAQ: ... conference call and webcast at 5:00 p.m. Eastern Time ... to discuss second quarter 2015 financial results and provide ... after the NASDAQ Global Select Market closes that day. ... dialing 877.643.7155 for domestic callers and 914.495.8552 for international ...
(Date:7/30/2015)... , July 30, 2015 EnteroMedics Inc. ... using neuroblocking technology to treat obesity, metabolic diseases and ... a conference call on Thursday, August 6, 2015, at ... the second quarter ended June 30, 2015, and to ... vBloc® Neurometabolic Therapy, delivered via the Maestro® System. ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 2EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 3
Cached News: